With the analysis among 48 patents, we discovered top 25 key players by total patent application. Astellas Pharma, Inc., Novartis AG, F. Hoffmann-La Roche Ltd. are dominant in this area. They take 33.33% of the total patent filing.
Tokyo-to, Japan
Patent: 10
Basel-Stadt, Switzerland
Patent: 3
Rheinland-Pfalz, Germany
Patent: 3
Massachusetts, United States
Patent: 2
Tianjin Shi, China
Patent: 2
Pennsylvania, United States
Patent: 2
Indiana, United States
Patent: 1
No data, please try another search term
With the analysis among related 22 patents applied in the last 5 years. We discover 10 most active companies in this area. The fast-growing Astellas Pharma, Inc., Tianjin Minxiang Biomedical Co., Ltd., Akebia Therapeutics, Inc. take 63.64% of patent filing during this period.
Tokyo-to, Japan
Patent: 10
Tianjin Shi, China
Patent: 2
Massachusetts, United States
Patent: 2
New York, United States
Patent: 1
Zhejiang Sheng, China
Patent: 1
Shanghai Shi, China
Patent: 1
Hebei Sheng, China
Patent: 1
Heilongjiang Sheng, China
Patent: 1
With the analysis among related 22 patents in last 5 years, we discover 10 new entrants. Astellas Pharma, Inc., Tianjin Minxiang Biomedical Co., Ltd., Akebia Therapeutics, Inc. are the most active new entrants in this area.
Tokyo-to, Japan
Patent: 10
Tianjin Shi, China
Patent: 2
Massachusetts, United States
Patent: 2
New York, United States
Patent: 1
Zhejiang Sheng, China
Patent: 1
Shanghai Shi, China
Patent: 1
Hebei Sheng, China
Patent: 1
Heilongjiang Sheng, China
Patent: 1
With the analysis among 5 patents, we discovered top 4 universities and scientific research institutions by total patent application. Nagoya Institute of Technology, Shanghai University of Traditional Chinese Medicine, Jiaxing University are dominant in this area. They take 60.00% of the total patent filing.
Aichi-ken, Japan
Patent: 1
Shanghai Shi, China
Patent: 1
Zhejiang Sheng, China
Patent: 1
Heilongjiang Sheng, China
Patent: 1